Clinical Trials Browser

Phase 2 × olaparib × Dermatologic × Clear all

NCT05524935 2026-01-08

Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma

Phase 2 Recruiting

Uveal Melanoma

NCT05482074 2024-01-19

Olaparib in Unresectable/Metastatic Melanoma With BRCA1/2

Phase 2 Withdrawn

Uveal Melanoma, Melanoma